Jasper Therapeutics Stock Net Asset

JSPR Stock  USD 23.09  0.53  2.24%   
Jasper Therapeutics fundamentals help investors to digest information that contributes to Jasper Therapeutics' financial success or failures. It also enables traders to predict the movement of Jasper Stock. The fundamental analysis module provides a way to measure Jasper Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jasper Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jasper Therapeutics Company Net Asset Analysis

Jasper Therapeutics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Jasper Therapeutics Net Asset

    
  94.89 M  
Most of Jasper Therapeutics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jasper Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Jasper Net Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Jasper Therapeutics is extremely important. It helps to project a fair market value of Jasper Stock properly, considering its historical fundamentals such as Net Asset. Since Jasper Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jasper Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jasper Therapeutics' interrelated accounts and indicators.
0.83-0.79-0.96-0.810.98-0.530.920.290.71.0-0.7-0.53-0.74-0.530.970.581.00.96-0.530.66
0.83-0.63-0.9-0.730.73-0.680.73-0.180.690.84-0.39-0.68-0.7-0.680.820.450.830.81-0.680.66
-0.79-0.630.720.94-0.820.56-0.94-0.39-0.71-0.760.830.560.610.56-0.9-0.61-0.78-0.830.56-0.93
-0.96-0.90.720.84-0.930.72-0.82-0.23-0.77-0.960.680.720.810.72-0.92-0.48-0.97-0.920.72-0.66
-0.81-0.730.940.84-0.850.81-0.87-0.39-0.86-0.790.870.810.780.81-0.89-0.46-0.83-0.830.81-0.94
0.980.73-0.82-0.93-0.85-0.550.910.480.710.97-0.82-0.55-0.75-0.550.960.560.980.95-0.550.67
-0.53-0.680.560.720.81-0.55-0.45-0.19-0.85-0.530.631.00.771.0-0.57-0.07-0.58-0.531.0-0.73
0.920.73-0.94-0.82-0.870.91-0.450.330.620.89-0.75-0.45-0.59-0.450.970.730.90.95-0.450.8
0.29-0.18-0.39-0.23-0.390.48-0.190.330.20.26-0.79-0.19-0.2-0.190.330.250.340.34-0.190.19
0.70.69-0.71-0.77-0.860.71-0.850.620.20.7-0.66-0.85-0.97-0.850.7-0.010.70.59-0.850.83
1.00.84-0.76-0.96-0.790.97-0.530.890.260.7-0.66-0.53-0.75-0.530.960.550.990.95-0.530.63
-0.7-0.390.830.680.87-0.820.63-0.75-0.79-0.66-0.660.630.610.63-0.77-0.46-0.73-0.740.63-0.72
-0.53-0.680.560.720.81-0.551.0-0.45-0.19-0.85-0.530.630.771.0-0.57-0.07-0.58-0.531.0-0.73
-0.74-0.70.610.810.78-0.750.77-0.59-0.2-0.97-0.750.610.770.77-0.690.06-0.74-0.590.77-0.7
-0.53-0.680.560.720.81-0.551.0-0.45-0.19-0.85-0.530.631.00.77-0.57-0.07-0.58-0.531.0-0.73
0.970.82-0.9-0.92-0.890.96-0.570.970.330.70.96-0.77-0.57-0.69-0.570.680.970.98-0.570.78
0.580.45-0.61-0.48-0.460.56-0.070.730.25-0.010.55-0.46-0.070.06-0.070.680.590.76-0.070.36
1.00.83-0.78-0.97-0.830.98-0.580.90.340.70.99-0.73-0.58-0.74-0.580.970.590.97-0.580.65
0.960.81-0.83-0.92-0.830.95-0.530.950.340.590.95-0.74-0.53-0.59-0.530.980.760.97-0.530.67
-0.53-0.680.560.720.81-0.551.0-0.45-0.19-0.85-0.530.631.00.771.0-0.57-0.07-0.58-0.53-0.73
0.660.66-0.93-0.66-0.940.67-0.730.80.190.830.63-0.72-0.73-0.7-0.730.780.360.650.67-0.73
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Jasper Total Assets

Total Assets

63.24 Million

At this time, Jasper Therapeutics' Total Assets are relatively stable compared to the past year.
Based on the recorded statements, Jasper Therapeutics has a Net Asset of 94.89 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Jasper Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jasper Therapeutics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jasper Therapeutics could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics of similar companies.
Jasper Therapeutics is currently under evaluation in net asset category among its peers.

Jasper Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Jasper Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Jasper Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Jasper Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Jasper Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Jasper Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Jasper Therapeutics' value.
Shares
Woodline Partners Lp2024-09-30
495.1 K
Braidwell Lp2024-09-30
483.3 K
Rock Springs Capital Management Lp2024-09-30
459.1 K
Great Point Partners Llc2024-06-30
402 K
Ally Bridge Group (ny) Llc2024-09-30
399.5 K
Opaleye Management Inc2024-09-30
353.5 K
Boxer Capital Llc2024-09-30
350 K
Integral Health Asset Management, Llc2024-09-30
350 K
Bank Of America Corp2024-06-30
325.3 K
Velan Capital Investment Management Lp2024-09-30
1.4 M
Soleus Capital Management, L.p.2024-09-30
1.3 M

Jasper Fundamentals

About Jasper Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jasper Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Jasper Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Jasper Stock

  0.47A Agilent TechnologiesPairCorr
  0.41ME 23Andme HoldingPairCorr
  0.37DOMH Dominari HoldingsPairCorr
  0.31VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.
The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.